AXL and breast carcinoma: For all experiments, miR-148b levels resulted increased in AXL+ 4175-TGL, but not in AXL- SKBR3 breast cancer cells following treatments with axl-148b conjugates compared to ctrl or GL21.T-treated cells, as measured by qRT-PCR analysis (Figure S5B and not shown).